Multicenter Phase III Study of Uracil/Tegafur and Oral Leucovorin Versus Fluorouracil and Leucovorin in Patients With Previously Untreated Metastatic Colorectal Cancer - Concepedia

Concepedia

Publication | Closed Access

Multicenter Phase III Study of Uracil/Tegafur and Oral Leucovorin Versus Fluorouracil and Leucovorin in Patients With Previously Untreated Metastatic Colorectal Cancer

322

Citations

37

References

2002

Year

Jean‐Yves Douillard, Paulo M. Hoff, Jamey Skillings, Peter D. Eisenberg, Neville Davidson, Peter Harper, Mark Vincent, Barry C. Lembersky, Seth Thompson, Antonella Maniero,

Journal of Clinical Oncology

Abstract

UFT/LV provided a safer, more convenient oral alternative to a standard bolus IV 5-FU/LV regimen for metastatic colorectal cancer while producing equivalent survival.

References

	Year	Citations

Page 1